Laboratory Corp (NYSE: LH) reported third-quarter 2025 adjusted earnings per share of $4.18 on Tuesday, up from $3.50 a year ago, beating the consensus of $4.18.

Sales increased 8.6% year-over-year to $3.56 billion, beating the consensus of $3.56 billion.

The increase was due to organic revenue growth of 6.2%, acquisitions, net of divestitures, 1.7%, and foreign currency translation of 0.7%.

Adjusted operating income for the quarter was $396.6 million, or 11.1% of revenue.

“Labcorp’s third-quarter performance reflects continued momentum in our Diagnostics and Central Laboratory businesses, resulting in strong revenue growth and margin improvement,” said Adam Schechter, chairman and CEO of Labcorp.

Also Read: Could Personalized Medicine ...